Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.

Bacterial aromatic polyketides such as tetracycline and doxorubicin are a medicinally important class of natural products produced as secondary metabolites by actinomyces bacteria. Their backbones are derived from malonyl-CoA units by polyketide synthases (PKSs). The nascent polyketide chain is synt...

Full description

Bibliographic Details
Main Authors: Yi Tang, Taek Soon Lee, Chaitan Khosla
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2004-02-01
Series:PLoS Biology
Online Access:http://europepmc.org/articles/PMC340942?pdf=render
_version_ 1831651272950808576
author Yi Tang
Taek Soon Lee
Chaitan Khosla
author_facet Yi Tang
Taek Soon Lee
Chaitan Khosla
author_sort Yi Tang
collection DOAJ
description Bacterial aromatic polyketides such as tetracycline and doxorubicin are a medicinally important class of natural products produced as secondary metabolites by actinomyces bacteria. Their backbones are derived from malonyl-CoA units by polyketide synthases (PKSs). The nascent polyketide chain is synthesized by the minimal PKS, a module consisting of four dissociated enzymes. Although the biosynthesis of most aromatic polyketide backbones is initiated through decarboxylation of a malonyl building block (which results in an acetate group), some polyketides, such as the estrogen receptor antagonist R1128, are derived from nonacetate primers. Understanding the mechanism of nonacetate priming can lead to biosynthesis of novel polyketides that have improved pharmacological properties. Recent biochemical analysis has shown that nonacetate priming is the result of stepwise activity of two dissociated PKS modules with orthogonal molecular recognition features. In these PKSs, an initiation module that synthesizes a starter unit is present in addition to the minimal PKS module. Here we describe a general method for the engineered biosynthesis of regioselectively modified aromatic polyketides. When coexpressed with the R1128 initiation module, the actinorhodin minimal PKS produced novel hexaketides with propionyl and isobutyryl primer units. Analogous octaketides could be synthesized by combining the tetracenomycin minimal PKS with the R1128 initiation module. Tailoring enzymes such as ketoreductases and cyclases were able to process the unnatural polyketides efficiently. Based upon these findings, hybrid PKSs were engineered to synthesize new anthraquinone antibiotics with predictable functional group modifications. Our results demonstrate that (i) bimodular aromatic PKSs present a general mechanism for priming aromatic polyketide backbones with nonacetate precursors; (ii) the minimal PKS controls polyketide chain length by counting the number of atoms incorporated into the backbone rather than the number of elongation cycles; and (iii) in contrast, auxiliary PKS enzymes such as ketoreductases, aromatases, and cyclases recognize specific functional groups in the backbone rather than overall chain length. Among the anthracyclines engineered in this study were compounds with (i) more superior activity than R1128 against the breast cancer cell line MCF-7 and (ii) inhibitory activity against glucose-6-phosphate translocase, an attractive target for the treatment of Type II diabetes.
first_indexed 2024-12-19T15:25:32Z
format Article
id doaj.art-735e1eab648746ba9c95df333129adb9
institution Directory Open Access Journal
issn 1544-9173
1545-7885
language English
last_indexed 2024-12-19T15:25:32Z
publishDate 2004-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Biology
spelling doaj.art-735e1eab648746ba9c95df333129adb92022-12-21T20:15:54ZengPublic Library of Science (PLoS)PLoS Biology1544-91731545-78852004-02-0122E3110.1371/journal.pbio.0020031Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.Yi TangTaek Soon LeeChaitan KhoslaBacterial aromatic polyketides such as tetracycline and doxorubicin are a medicinally important class of natural products produced as secondary metabolites by actinomyces bacteria. Their backbones are derived from malonyl-CoA units by polyketide synthases (PKSs). The nascent polyketide chain is synthesized by the minimal PKS, a module consisting of four dissociated enzymes. Although the biosynthesis of most aromatic polyketide backbones is initiated through decarboxylation of a malonyl building block (which results in an acetate group), some polyketides, such as the estrogen receptor antagonist R1128, are derived from nonacetate primers. Understanding the mechanism of nonacetate priming can lead to biosynthesis of novel polyketides that have improved pharmacological properties. Recent biochemical analysis has shown that nonacetate priming is the result of stepwise activity of two dissociated PKS modules with orthogonal molecular recognition features. In these PKSs, an initiation module that synthesizes a starter unit is present in addition to the minimal PKS module. Here we describe a general method for the engineered biosynthesis of regioselectively modified aromatic polyketides. When coexpressed with the R1128 initiation module, the actinorhodin minimal PKS produced novel hexaketides with propionyl and isobutyryl primer units. Analogous octaketides could be synthesized by combining the tetracenomycin minimal PKS with the R1128 initiation module. Tailoring enzymes such as ketoreductases and cyclases were able to process the unnatural polyketides efficiently. Based upon these findings, hybrid PKSs were engineered to synthesize new anthraquinone antibiotics with predictable functional group modifications. Our results demonstrate that (i) bimodular aromatic PKSs present a general mechanism for priming aromatic polyketide backbones with nonacetate precursors; (ii) the minimal PKS controls polyketide chain length by counting the number of atoms incorporated into the backbone rather than the number of elongation cycles; and (iii) in contrast, auxiliary PKS enzymes such as ketoreductases, aromatases, and cyclases recognize specific functional groups in the backbone rather than overall chain length. Among the anthracyclines engineered in this study were compounds with (i) more superior activity than R1128 against the breast cancer cell line MCF-7 and (ii) inhibitory activity against glucose-6-phosphate translocase, an attractive target for the treatment of Type II diabetes.http://europepmc.org/articles/PMC340942?pdf=render
spellingShingle Yi Tang
Taek Soon Lee
Chaitan Khosla
Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.
PLoS Biology
title Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.
title_full Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.
title_fullStr Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.
title_full_unstemmed Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.
title_short Engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases.
title_sort engineered biosynthesis of regioselectively modified aromatic polyketides using bimodular polyketide synthases
url http://europepmc.org/articles/PMC340942?pdf=render
work_keys_str_mv AT yitang engineeredbiosynthesisofregioselectivelymodifiedaromaticpolyketidesusingbimodularpolyketidesynthases
AT taeksoonlee engineeredbiosynthesisofregioselectivelymodifiedaromaticpolyketidesusingbimodularpolyketidesynthases
AT chaitankhosla engineeredbiosynthesisofregioselectivelymodifiedaromaticpolyketidesusingbimodularpolyketidesynthases